In this context, our findings that NSAIDs with anti-cancer activity induce high levels of mda-7/IL-24 in ovarian cancer cells provide a new therapeutic strategy to enhance mda-7/IL-24 levels on a systemic level. The gene discussed is IL24; the disease is ovarian carcinoma.